Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer

Minkyung Lee1, Hae-June Lee2, In Suh Park3

  • 1Department of Nuclear Medicine, School of Medicine, Inha University, Incheon, South Korea.

Neuropharmacology
|February 11, 2018
PubMed

Insights

This study found reduced metabotropic glutamate receptor 5 (mGluR5) expression in the brains of advanced Alzheimer's disease (AD) mouse models. Positron emission tomography and immunoassay confirmed lower mGluR5 levels, particularly in the limbic system.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Medical Imaging

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Metabotropic glutamate receptor 5 (mGluR5) plays a role in synaptic plasticity and neuronal function.
  • Dysregulation of mGluR5 has been implicated in AD pathogenesis.

Purpose of the Study:

  • To investigate functional changes in mGluR5 expression in an advanced AD mouse model (5xFAD).
  • To quantify mGluR5 levels using positron emission tomography (PET) and immunoassay techniques.

Main Methods:

  • Utilized PET imaging with the mGluR5-specific radiotracer [18F]FPEB in 5xFAD and wild-type mice.
  • Quantified non-displaceable binding potential (BPND) using Logan's graphical analysis.
  • Validated PET findings through immunoblotting of brain tissue protein isolates.

Main Results:

  • PET imaging revealed significantly lower radioactivities in the hippocampus and striatum of 5xFAD mice compared to controls.
  • Estimated mGluR5 binding values were significantly reduced in 5xFAD mice.
  • Immunoblotting confirmed lower mGluR5 protein intensity in 5xFAD mice brain tissues.

Conclusions:

  • mGluR5 levels are significantly down-regulated in the limbic system of the 5xFAD mouse model of Alzheimer's disease.
  • These findings suggest a potential role for mGluR5 dysregulation in AD progression.
  • PET imaging with [18F]FPEB is a viable method for assessing mGluR5 changes in AD models.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
987
Density00:56

Density

Density is an important characteristic of substances, crucial in determining whether an object sinks or floats in a fluid. Its SI unit is kg/m3, and its cgs unit is g/cm3. The density of an object helps in identifying its composition, and also reveals information about the phase of the matter and its substructure. The densities of liquids and solids are roughly comparable, consistent with the fact that their atoms are in close contact. However, gases have much lower densities than liquids and...
20.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Current Density01:21

Current Density

The total amount of current flowing through one unit value of a cross-sectional area is referred to as current density. If the current flow is uniform, the amount of current flowing through a conductor is the same at all points along the conductor, even if the conductor area varies. The current density consists of the local magnitude and direction of the charge flow, which varies from point to point. Current density is measured in amperes per meter square, and direction is defined as the net...
5.2K
Strain-Energy Density01:20

Strain-Energy Density

Understanding the strain energy density in materials under axial load is crucial for evaluating their mechanical behavior and durability. When a rod is subjected to such a load, it elongates and stores energy, known as strain energy, as potential energy within the material. This energy is measured in terms of energy per unit volume.
In the elastic region of a material, the relationship between the stress and the strain is linear and follows Hooke's Law. The strain energy density in this region...
947